At Close: IBB down 2.35% to 342 at May bottom, XBI up 0.64% to 218
—-
Two Hours to Go 2:15p EDT, NASDAQ Down 1.79% at 4792, IBB at $349
Biotech Breakdown: Relief Today Or Another Head Fake?
Biotech stocks are trying to hold the May lows with the IBB at $342 but now at $349. There is bit of buying today and most biotechnology […]
About Raynovich Rod
Rod Raynovich is an experienced biotech investor and analyst with a focus in vaccines, tools, IVD’s and biopharmaceuticals. Prior to starting Raygent.com, he was a former technology transfer office at UCLA and he has held various executive positions in the biotech and medical device industry, including senior positions at NASDAQ listed biomedical companies. Prior to that Mr.Raynovich held […]
NASDAQ leads -up 0.6% to 4787
The October correction of ~7% was a “headfake” as macro events scared many investor away
Technology and Healthcare Stocks Lead The Way
The healthcare SPDR (XLV) is up 24.5% YTD and the technology SPDR (XLK) is up 18% YTD.
Biotech stocks are at new highs with all major ETFs rallying in November. Our top ETF pick FBT is […]
